Apologies in advance for the "cross promotion" and this is in no way an endorsement for or against the company, but for those interested in better shareholder communications, I suggest you take a look at todays quarterly update from Pharmaxis. Documents of this detail come out every quarter and give shareholders like myself a good opportunity to really see what's going on, for better or worse.
http://www.pharmaxis.com.au/assets/...arterly-Shareholder-Update-September-2016.pdf
And I can promise you that Pharmaxis have much fewer resources at their disposal than Sirtex, and yet they manage to do a far better job of shareholder engagement.
Ann: CEO's AGM Address and Presentation-SRX.AX, page-58
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.5¢ | $292.8K | 1.630M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 7394560 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1260654 | 10 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |